IP Library › Assignment 063394/0831
Patent Assignment
Reel/Frame 063394/0831

Change of Name

Recorded: 2023-04-21 Pages: 3
Assignor
ULTIMOVACS AS
Executed: 2023-03-20
Assignee
ULTIMOVACS ASA
ULLERNCHAUSSÉEN 64, OSLO, 0379, NORWAY
Covered Properties (6)
Telomerase Polypeptide Vaccine for Treating Cancer
Patent: 9,657,068 →
Application: 13/578,969 →
Publication: US 2013/0129760
Telomerase Polypeptide Vaccine for Treating Cancer
Application: 15/498,728 →
Publication: US 2017/0232087
Telomerase Polypeptide Vaccine for Treating Cancer
Application: 15/498,733 →
Publication: US 2017/0232088
A Vaccine in Combination with an Immune Checkpoint Inhibitor for Use in Treating Cancer
Application: 16/306,352 →
Publication: US 2019/0247482
Telomerase Polypeptide Vaccine for Treating Cancer
Application: 16/712,167 →
Publication: US 2020/0121771
Vaccine in Combination with an Immune Checkpoint Inhibitor for Use in Treating Cancer
Application: 17/818,584 →
Publication: US 2023/0049012
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 14, 2012
From: GAUDERNACK, GUSTAV; SUSO, ELSE MARIT INDERBERG; RASMUSSEN, ANNE-MARIE
To: OSLO UNIVERSITY HOSPITAL HF
Reel/Frame 029471/0299 →
Assignment of Assignor's Interest Oct 7, 2015
From: OSLO UNIVERSITY HOSPITAL HF
To: ULTIMOVACS AS
Reel/Frame 036808/0034 →
Corrective Assignment to Correct the Assignee Street Address and Postal Code Previously Recorded at Reel: 036808 Frame: 0034. Assignor(S) Hereby Confirms the Assignee Address Change. Feb 4, 2016
From: OSLO UNIVERSITY HOSPITAL HF
To: ULTIMOVACS AS
Reel/Frame 037731/0415 →
Assignment of Assignor's Interest Apr 2, 2019
From: GAUDERNACK, GUSTAV; TORNES, AUDUN
To: ULTIMOVACS AS
Reel/Frame 048774/0970 →